FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:431-432 February 11, 1993 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

In the 26 years since Ashbaugh et al.¹ first described the adult respiratory distress syndrome (ARDS), we have progressed considerably in our understanding of the pathogenesis of this disorder. Unfortunately, we have made much less progress in our ability to improve its outcome. In this issue of the Journal, Rossaint et al. describe a new treatment for ARDS -- inhaled nitric oxide². Their results may represent an important advance in therapy for ARDS.

ARDS may sometimes result from direct injury to the lungs (for example, from aspiration of gastric contents, pneumonia, or inhalation of a toxic substance); it may . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Kenyon, N. J., Albertson, T. E. (2002). Steroids and Sepsis: Time for Another Reevaluation. J Intensive Care Med 17: 68-74 [Abstract]